BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20863342)

  • 21. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Herpes zoster and postherpetic neuralgia: advantages of the vaccination].
    Cañada JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():19-21. PubMed ID: 20084344
    [No Abstract]   [Full Text] [Related]  

  • 25. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
    Afonina NM; Mikheeva IV
    Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shingrix--an adjuvanted, recombinant herpes zoster vaccine.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):195-196. PubMed ID: 29186082
    [No Abstract]   [Full Text] [Related]  

  • 31. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly.
    Opstelten W; van Essen GA; Hak E
    Vaccine; 2009 Jan; 27(2):192-6. PubMed ID: 18996427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination to prevent herpes zoster and postherpetic neuralgia.
    Oxman MN
    Hum Vaccin; 2007; 3(2):64-8. PubMed ID: 17299270
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune senescence and vaccines to prevent herpes zoster in older persons.
    Levin MJ
    Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two U.S. experts discuss the consequences of the "Shingles Prevention Study". Is senior vaccination worthwhile in the practice?].
    MMW Fortschr Med; 2006; Spec no.1():16. PubMed ID: 16872128
    [No Abstract]   [Full Text] [Related]  

  • 37. Varicella-zoster vaccine.
    Senanayake SN
    N Engl J Med; 2007 Jul; 357(1):89-90. PubMed ID: 17615639
    [No Abstract]   [Full Text] [Related]  

  • 38. Herpes zoster: epidemiology, natural history, and common complications.
    Weinberg JM
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S130-5. PubMed ID: 18021864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study.
    Tseng HF; Liu A; Sy L; Marcy SM; Fireman B; Weintraub E; Baggs J; Weinmann S; Baxter R; Nordin J; Daley MF; Jackson L; Jacobsen SJ;
    J Intern Med; 2012 May; 271(5):510-20. PubMed ID: 22026504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
    Burke MS
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.